Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment

Intern Med. 2019;58(18):2703-2709. doi: 10.2169/internalmedicine.2570-18. Epub 2019 Sep 15.

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by reactivation of the JC virus under an immunosuppressed state. This condition carries a high risk of cryptococcal meningitis. We herein report a 65-year-old woman who simultaneously developed PML and cryptococcal meningitis and presented with bilateral sixth nerve palsy. She had been treated with methotrexate and infliximab for rheumatoid arthritis. Her symptoms improved with antifungal drug treatment and discontinuation of immunosuppression therapy. Although concurrent PML and cryptococcal meningitis is rare, it should be considered in immunosuppressed patients.

Keywords: JC virus; cryptococcal meningitis; infliximab; methotrexate; progressive multifocal leukoencephalopathy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use*
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Infliximab / adverse effects*
  • Infliximab / therapeutic use
  • JC Virus / isolation & purification
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Leukoencephalopathy, Progressive Multifocal / etiology
  • Meningitis, Cryptococcal / drug therapy*
  • Meningitis, Cryptococcal / etiology
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Antirheumatic Agents
  • Infliximab
  • Methotrexate